Browse > Article
http://dx.doi.org/10.5012/bkcs.2010.31.04.874

Structure-Activity Relationships of 13- and 14-Membered Cyclic Partial Retro-Inverso Pentapeptides Related to Enkephalin  

Hong, Nam-Joo (School of Biotechnology, Yeungnam University)
Publication Information
Abstract
A series of 13- and 14-membered cyclic enkephalin analogs based on the moderately $\mu$ selective prototype compound Tyr-C[D-$A_2bu$-Gly-Phe-Leu] 8a were synthesized to investigate the structure-activity relationship. The modifications of sequence were mainly focused on two positions 3 and 5, critical for the selective recognition for $\mu$ and $\delta$ opioid receptors. The substitution of hydrophobic $Leu^5$ with hydrophilic $Asp^5$ derivatives led to Tyr-C[D-$A_2bu$-Gly-Phe-Asp(N-Me)] 7 and Tyr-C[D-Glu-Phe-gPhe-rAsp(O-Me)] 5, the peptides with a large affinity losses at both $\mu$ and $\delta$ receptors. The substitution of $Phe^3$ with $Gly^3$ led to Tyr-C[D-Glu-Gly-gPhe-rLeu] 3 and Tyr-C[D-Glu-Gly-gPhe-D-rLeu] 4, the peptides with large affinity losses at $\mu$ receptors, indicating the critical role of phenyl ring of $Phe^3$ for $\mu$ receptor affinities. One atom reduction of the ring size from 14-membered analogs Tyr-C[D-Glu-Phe-gPhe-(L and D)-rLeu] 6a, 6b to 13-membered analogs Tyr-C[D-Asp-Phe-gPhe-(L and D)-rLeu] 1, 2 reduced the affinity at both $\mu$ and $\delta$ receptors, but increased the potency in the nociceptive assay, indicating the ring constrain is attributed to high nociceptive potency of the analogs. For the influence of D- or L-chirality of $Leu^5$ on the receptor selectivity, regardless of chirality and ring size, all cyclic diastereomers displayed marked $\mu$ selectivity with low potencies at the $\delta$ receptor. The retro-inverso analogs display similar or more active at $\mu$ receptor, but less active at $\delta$ receptor than the parent analogs.
Keywords
Cyclic-enkephalin; Synthesis; Bioactivity;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
Times Cited By Web Of Science : 1  (Related Records In Web of Science)
Times Cited By SCOPUS : 2
연도 인용수 순위
1 Martin, W. R.; Eades, C. G.; Thompson, J. J.; Huppler, R. E.; Gilbert,P. E. J. Pharmacol. Exp. Ther. 1976, 197, 517.
2 Lord, J. A. H.; Waterfield, A. A.; Hughes, J.; Kosterlitz, H. W. Nature(London) 1977, 267, 495.   DOI   ScienceOn
3 Weltrowska, G. Bioorg. Med. Chem. Lett. 2004, 14, 4731.   DOI   ScienceOn
4 Herz, A.; Blasig, J.; Emrich, H. M.; Cording, C.; Piree, S.; Kolling,A.; Zerssen, K. V. In The Endorphins, Advanced in Biochemical Psychopharmacology; Costa, E.,Travucchi, M., Eds.; Raven: New York, 1978; Vol. 18, p 333.
5 Gacel, G.; Gournie-Zaluski, M. C.; Fellion, E.; Roques, V. P. J. Med. Chem. 1981, 24, 1119.   DOI
6 Chang, K. J.; Cuatrecassas, P.; Wei, E. T.; Chang, J. K. Life Sci.1982, 30, 1547.   DOI   ScienceOn
7 Fang, J. F.; fields, H. L.; Lee, N. M. J. Pharmacol. Exp. Ther. 1986, 238, 1039.
8 Stein, L.; Belluzzi, J. K. In The Endorphins, Advances In Biochemical Psychopharmacology; Costa, E., Travucchi, M., Eds.; Raven:New York, 1978; Vol. 18, p 299.
9 Roques, B. P. J. Pharmacol. 1986, 16, 5.
10 Fournie-Zaluski, M. C.; Facel, G.; Maigret, B.; Prelimat, S.; Roques,B. P. Mol. Pharmacol. 1981, 20, 484.
11 Burgen, A. S. V.; Roberts, G. C. K.; Feeney, J. Nature (London)1975, 253, 753.   DOI   ScienceOn
12 Maigret, B.; Fournie-Zaluski, M. C.; Roques, B. P.; Premilat, S.Mol. Pharmacol. 1985, 29, 314.
13 Goodman, M.; Chorev, M. In Perspective in Peptide Chemistry;Eberle, R., Geiger and Wieland, T., Eds.; Karger Basel: 1981; p283.
14 Weltrowska, G.; Nguyen, T.; Lemieux, C.; Chung, N.; Schiller, P.Chem. Biol. Drug Desig. 2008, 72, 337.   DOI   ScienceOn
15 Witkowska, R.; Chung, N.; Schiller, P.; Zabrocki, J. J. Pept. Sci.2005, 11, 361.   DOI   ScienceOn
16 Chen, H.; Chung, N.; Lemieux, C.; Zelent, B.; Wilkes, C.; Schiller, P. Pept. Sci. 2005, 80, 325.   DOI   ScienceOn
17 Yatsh, T.; Jang, J. D.; Braun, K.; Goodman, M. Life Sci. 1991, 48,623.   DOI   ScienceOn
18 Chang, J. K.; Fong, T. W. Life Sci. 1976, 18, 1473.   DOI   ScienceOn
19 Wilkes, B. C.; Schiller, P. W. Biopolymers 1987, 26, 1431.   DOI   ScienceOn
20 Shenderovich, M. D.; Nikiforovich, G. V.; Golbraikh, A. A. Int. J. Pept. Pro. Res. 1991, 37, 241.
21 Mierke, D. F.; Luccietto, P.; Schiller, P. W.; Goodman, M. Biopolymers1987, 26, 1573.   DOI   ScienceOn
22 Said-Nejad, O. E.; Felder, E. R.; Mierke, D. F.; Yamazaki, T.;Schiller, P. W. Inter. J. Pept. Pro. Res. 1992, 39, 145.
23 Shenderovich, M. M.; Nikiforovich, G. V.; Golbrakh, A. A. Int. J. Peptide Protein Res. 1991, 37, 241.
24 Katarzyna, F.; Marta, O.; Jacek, W.; Chung, N.; Schiller, P. W.;Danuta, P.; Agnieszka, Z.; Agnieszka, P.; Ewa, W.; Jan, I. J. Pept. Sci. 2005, 11(6), 347.   DOI   ScienceOn
25 Agnieszka, Z.; Sylwia, R.; Ukasz, R.; Nga, N. C.; Cezary, C.;Ewa, W.; Schiller, P. W.; Jerzy Ci, J. I. J. Pept. Sci. 2008, 14(7),830.   DOI   ScienceOn
26 Mosberg, H. I.; Hurst, R.; Hruby, V. J.; Galligan, J. J.; Burks, T. F.;Gee, K.; Yamamura, H. I. Life Sci. 1983, 32, 2565.   DOI   ScienceOn
27 Wilkes, B. C.; Schiller, P. W. Biopolymers 1990, 29, 89.   DOI   ScienceOn
28 Yamazaki, T.; Said Nejad, O. E.; Schiller, P. W.; Goodman, M.Biopolymers 1991, 31, 877.   DOI   ScienceOn
29 Schiller, P. W.; Nguyen, R. M. D.; Lemieux, C.; Maziak, L. A. J. Med. Chem. 1985, 28, 1766.   DOI
30 Schiller, P. W.; Nguyen, T. M. D.; Maziak, L. A.; Wilkes, B. C.; Lemieux,C. J. Med. Chem. 1987, 30, 2094.   DOI
31 Schiller, P. W.; Wilkes, B. C. In Recent Progress in the Chemistry and Biology of Opioid Peptides, (NIDA Research Monograph 87); Rapake, R. S., Dhawan, B. N., Eds.; U. S. Government PrintingOffice: Washington, DC, 1988; p 60.
32 Mammi, N. J.; Hassan, M.; Goodman, M. J. Am. Chem. Soc. 1985,107, 4008.   DOI
33 Berman, J. M.; Goodman, M.; Nguyen, T. M. D.; Schiller P. W.Biochem. Biophys. Res. Comm. 1983, 155, 864.
34 Goodman, M.; Ro, S.; Yamazaki, T.; Spencer, J. R.; Toy, A.;Huang, Z.; He, Y.; Reisine, T. Bioorg. Khim. 1992, 18, 1375.
35 Yamazaki, T.; Mierke, D. F.; Said-Nejad, O. E.; Felder, E. R.;Goodman, M. Int. J. Pept. Pro. Res. 1992, 39, 161.
36 Mosberg, H. I.; Omnaas, J. R.; Medzihradsky, J.; Smith, C. B. Life Sci. 1988, 43, 1013.   DOI   ScienceOn
37 DiMaio, J.; Nguyen, J. M. D.; Lenieux, C.; Schiller, P. W. J. Med. Chem. 1982, 25, 1432.   DOI
38 Svensson, C. I.; Rew, Y.; Malkmus, S.; Schiller, P. W.; Taulane, J. P.; Goodman, M.; Yaksh, T. L. J. Pharm. Exp. Ther. 2003, 304, 827.   DOI   ScienceOn
39 Rew, Y.; Malkmus, S.; Svensson, C.; Yaksh, T. L.; Chung N. N.;Schiller, P. W.; Cassel, j. A.; DeHaven, R. N.; Taulane, J. P.; Goodman,M. J. Med. Chem. 2002, 45, 3746.   DOI   ScienceOn
40 Schiller, P. W.; Nguyen, T. M.; Maziak, L. A.; Wilkes, B. C.; Lemieux,C. J. Med. Chem. 1987, 30, 2094.   DOI
41 Ciarkowski, J.; Zieleniak, A.; Rodziewicz-Motowidlo, S.; Rusak,L.; Chung, N. N.; Czaplewski ,C.; Witkowska, E.; Schiller, P. W.;Izdebski, J. Adv. Exp. Med. Biol. 2009, 611, 491.   DOI
42 Rew, Y.; Goodman, M. J. Org. Chem. 2002, 67, 8820.   DOI   ScienceOn
43 Berezowska, I.; Chung, N. N.; Lemieux, C.; Wilkes, B. C.; Schiller,P. W. J. Med. Chem. 2007, 50, 1414.   DOI   ScienceOn
44 Berezowska, I.; Chung, N. N.; Lemieux, C.; Wilkes, B. C.; Schiller,P. W. Acta Biochim. Pol. 2006, 53, 73.
45 Goodman, M.; Ro, S.; George, O.; Yamazaki, T.; Polinsky, A.NIDA Res. Monog. 1993, 134, 195.
46 Wilkes, B. C.; Schiller, P. Bioplymers 1990, 29, 89.   DOI   ScienceOn
47 Hong, N. J.; Jin, D. H.; Hong, E. Y. Bull. Korean Chem. Soc. 2009,30, 599.   DOI   ScienceOn
48 Paton, W. P. Br. J. Pharmacol. 1957, 12, 119.
49 Henderson, G.; Hughes, J.; Kosterlitz, H. W., Jr. J. Pharmacol.1971, 46, 764.